RPG Life Sciences Limited (NSE:RPGLIFE)
2,262.70
-18.90 (-0.83%)
Aug 14, 2025, 3:29 PM IST
RPG Life Sciences Market Cap
RPG Life Sciences has a market cap or net worth of 37.42 billion as of August 15, 2025. Its market cap has increased by 14.08% in one year.
Market Cap
37.42B
Enterprise Value
34.78B
Revenue
6.57B
Ranking
n/a
PE Ratio
20.47
Stock Price
2,262.70
Market Cap Chart
Since June 10, 2008, RPG Life Sciences's market cap has increased from 645.16M to 37.42B, an increase of 5,700.54%. That is a compound annual growth rate of 26.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 37.42B | 3.58% |
Dec 31, 2024 | 36.13B | 63.53% |
Dec 29, 2023 | 22.09B | 57.71% |
Dec 30, 2022 | 14.01B | 37.00% |
Dec 31, 2021 | 10.23B | 67.61% |
Dec 31, 2020 | 6.10B | 18.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,938.27B |
Divi's Laboratories | 1,627.99B |
Cipla | 1,263.32B |
Apollo Hospitals Enterprise | 1,124.61B |
Mankind Pharma | 1,020.51B |
Zydus Lifesciences | 994.96B |
Fortis Healthcare | 703.62B |
Alkem Laboratories | 639.37B |